• Are at high risk of getting more serious symptoms.
• Have tested positive for COVID-19.
• Are not in the hospital but have mild to moderate symptoms for 5 days or less.

Ask your healthcare provider for more information on Paxlovid and Lagevrio, two antiviral medications that require a prescription from a healthcare professional.

CDC has created a new tool: COVID-19 Quarantine and Isolation (Q&I) Calculator to help provide an easy- to-use way for people to follow the CDC’s guidance on quarantine and isolation and get customized information to address their unique situation.

This tool does not apply to cases and close contacts identified in certain settings. Parents with children in K-12 schools or early care and education (ECE) programs should consult the program administrator for specific isolation and quarantine guidance in their school or ECE setting. For information about isolation and quarantine in high-risk congregate settings and healthcare settings, refer to COVID-19 Quarantine and Isolation.

Click here

Coronaviruses are a large family of viruses that are common in people and many different species of animals, including camels, cattle, cats, and bats. COVID-19 is a novel or new coronavirus believed to have originated in China in 2019.

Reported illnesses range from mild to severe, including death. Symptoms may appear 2-14 days after exposure and be similar to influenza, including fever, cough and shortness of breath. Both coronavirus and influenza are spread by close contact between people and droplets produced when an infected person coughs or sneezes.

If you think you have been exposed to COVID19 and develop these symptoms, you should call your healthcare provider for medical advice. If you are unable to be seen by a healthcare professional, your insurance carrier may be able to provide telehealth services to evaluate you. Contact your insurance carrier for information and availability.

If a healthcare provider believes you should be tested, that person will coordinate the testing process. It is important that if you need to visit your doctor, emergency room, or urgent care setting, call ahead so that the healthcare center can take steps to keep other people from getting infected or exposed.

Please click here to download Covid testing centers. – Updated on 03/24/2022.

The U.S. Food and Drug Administration (FDA) and Centers for Disease Control and Prevention (CDC) have authorized a second booster dose for individuals who are at the highest risk for severe illness or death from COVID-19. This authorization will provide high-risk individuals another layer of protection against the effects of COVID-19.

Individuals eligible to receive a second booster dose (as identified by the Ohio Department of Health) include:

• People age 50 and older who received an initial mRNA booster dose (Pfizer or Moderna) at least four months ago MAY RECEIVE a second booster dose of an mRNA COVID-19 vaccine. A second booster dose may be most beneficial for people who are age 65 and older, or who are age 50-64 with certain underlying medical conditions.
• People age 12 and older who are moderately to severely immunocompromised who received an initial mRNA booster dose (Pfizer or Moderna) at least four months ago MAY RECEIVE a second booster dose of an mRNA COVID-19 vaccine (Pfizer, age 12+; Moderna, age 18+). This means individuals age 12 years and older who are moderately to severely immunocompromised may receive as many as five doses – the recommended three-dose primary series for people who are immunocompromised, plus two booster doses.
• Based on a newly published CDC report, adults who received a primary vaccine and booster dose of the Johnson & Johnson (Janssen) COVID-19 vaccine at least 4 months ago MAY RECEIVE a second booster dose using an mRNA COVID-19 vaccine.

Eligible individuals should talk to their healthcare providers to assess individual risks and the benefits of another dose in strengthening ongoing protection.

To make an appointment for a booster dose at the Seneca County General Health District, call (419) 447-3691 ext. 6333.